TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2025

Updated Overall Survival Analysis From the Phase II PHAROS Study of Encorafenib Plus Binimetinib in Patients With BRAF V600E-Mutant Metastatic Non-Small Cell Lung Cancer.

Melissa L Johnson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.